PSEN1 and Alzheimer disease: Transgenic mice expressing human APP, with or without human PSEN1, have consistent brain plaque formation, gliosis, decreased levels of synaptic markers and impairment of spatial memory tasks, in the cortex and hippocampus, as is also evidenced in human AD.